Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms
Histone deacetylase inhibitors (HDACIs) represent a well-known class of compounds that exhibit potential therapeutic efficacy in a variety of diseases, particularly cancer and neurodegenerative disorders. This article discusses the development of compound 6 as a new HDAC inhibitor. It was designed b...
Saved in:
| Main Authors: | Rosaline Ashraf, Mai Adel, Rabah A. T. Serya, Khaled A. M. Abouzid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ain Shams University
2023-12-01
|
| Series: | Archives of Pharmaceutical Sciences Ain Shams University |
| Subjects: | |
| Online Access: | https://aps.journals.ekb.eg/article_320650.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
by: Dandan Yuan, et al.
Published: (2025-12-01) -
Purification of 89Zr by Hydroxamate-Based Resins
by: Li-qiang WANG, et al.
Published: (2024-12-01) -
Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01) -
HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01) -
Nucleic acid binding affinity and antioxidant activity of N-m-Tolyl-4-Chlorophenoxyacetohydroxamicacid
by: Rubi Khilari, et al.
Published: (2024-09-01)